A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma-Reference-Cited by-同舟云学术

A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma

Published:2016-01 Issue:1 Volume:26 Page:144-149
ISSN:1050-7256
Container-title:Thyroid
language:en
Short-container-title:Thyroid

Author:

Brito Juan P.¹,Ito Yasuhiro²,Miyauchi Akira²,Tuttle R. Michael¹

Affiliation:

1. Endocrinology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

2. Department of Surgery, Kuma Hospital, Kobe, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/thy.2015.0178

Reference32 articles.

1. Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods

2. Current Thyroid Cancer Trends in the United States

3. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours

4. An Observational Trial for Papillary Thyroid Microcarcinoma in Japanese Patients

5. Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and Outcomes

Cited by 271 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Papillary thyroid microcarcinoma: Does management differ based on facility variables?;American Journal of Otolaryngology;2024-11

2. Impact of a simple informative leaflet on Brazilian doctors' attitudes towards active surveillance of thyroid microcarcinomas;Heliyon;2024-09

3. Thyroid nodules: diagnosis and management;Nature Reviews Endocrinology;2024-08-16

4. Active surveillance vs. surgery in low‐risk papillary thyroid microcarcinoma patients and the risk of loss to follow‐up;Cancer Medicine;2024-08

5. Racial–Ethnic Comparison of Treatment for Papillary Thyroid Cancer in the Military Health System;Annals of Surgical Oncology;2024-07-31